Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

2.785 -0.045 (-1.59%)
Streaming Delayed Price Updated: 9:43 AM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about MannKind Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
Conference Call to Begin Today at 5:00 p.m. (ET) 
From MannKind
Via GlobeNewswire
News headline image
Earnings Scheduled For February 27, 2024 ↗
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
News headline image
MannKind Earnings Preview ↗
 
Via Benzinga
News headline image
MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
From MannKind
Via GlobeNewswire
News headline image
MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®
From MannKind
Via GlobeNewswire
News headline image
A Preview Of MannKind's Earnings ↗
 
Via Benzinga
News headline image
Why MannKind Stock Soared 19% Higher on Tuesday ↗
The biotech delivered quite an impressive earnings report. 
Via The Motley Fool
News headline image
3 Biotech Stocks to Sell in January Before They Crash and Burn ↗
The biotech industry is one of the most profitable though risky at the same time. Here are three biotech stocks to sell. 
Via InvestorPlace
News headline image
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Longboard Pharmaceuticals, Inc. 
Via Benzinga
News headline image
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
From MannKind
Via GlobeNewswire
News headline image
MannKind (MNKD) Q2 2023 Earnings Call Transcript ↗
MNKD earnings call for the period ending June 30, 2023. 
Via The Motley Fool
News headline image
Earnings Preview For MannKind ↗
 
Via Benzinga
News headline image
MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
From MannKind
Via GlobeNewswire
News headline image
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results. 
Via Benzinga
News headline image
High-Yield Haven: 3 Dividend Stocks to Secure Now ↗
These are three different dividend stocks that have a great dividend yield and offer a reliable source of income. 
Via InvestorPlace
News headline image
MannKind (MNKD) Q3 2023 Earnings Call Transcript ↗
MNKD earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
News headline image
MannKind Corporation Reports 2023 Third Quarter Financial Results
From MannKind
Via GlobeNewswire
News headline image
MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes
From MannKind
Via GlobeNewswire
News headline image
MannKind Corporation to Hold 2023 Third Quarter Financial Results Conference Call on November 7, 2023
From MannKind
Via GlobeNewswire
News headline image
MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent
From MannKind
Via GlobeNewswire
News headline image
MannKind Analyst Turns Bullish, Says 'Don't Call It Comeback' ↗
Shares of MannKind Corp (NASDAQ: MNKD) were climbing in early trading on Tuesday. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 ↗
 
Via Benzinga
News headline image
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth ↗
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners. 
Via InvestorPlace
News headline image
MannKind Corporation Announces Participation at Upcoming Conferences
From MannKind
Via GlobeNewswire
News headline image
3 Biotech Stocks to Sell in August Before They Crash and Burn ↗
These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late. 
Via InvestorPlace
News headline image
Intuit To Rally More Than 20%? Here Are 10 Other Analyst Forecasts For Monday ↗
Keybanc lowered the price target for Bumble Inc. (NASDAQ: BMBL) from $25 to $24. Keybanc analyst Justin Patterson maintained an Overweight rating. Bumble shares rose 0.9% to $16.65 in pre-market... 
Via Benzinga
News headline image
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
News headline image
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
News headline image
MannKind Corporation Reports 2023 Second Quarter Financial Results
From MannKind
Via GlobeNewswire
News headline image
MannKind Corporation Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference
From MannKind
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.